Investor Presentaiton slide image

Investor Presentaiton

Balance Sheet (NIS millions) חברת החשמל Israel Electric Assets Current assets 12/31/2021 09/30/2021 09/30/2022 Liabilities and Equity 12/31/2021 09/30/2021 09/30/2022 Current liabilities Cash and cash equivalents 2,454 1,218 2,110 Credit from banks and other credit providers 5,425 4,037 5,467 Short term investments 332 348 448 Trade payables 2,786 3,179 4,490 Trade receivables for sales of electricity 4,290 5,824 5,757 Other current liabilities 1,238 1,668 1,552 Other current assets 665 795 1,074 Inventory - fuel 1,489 933 2,999 Customer advances, net of work in progress Provisions 740 700 829 686 726 671 Inventory stores 128 144 139 Liabillities of disposal groups classified as held for sale 147 Assets of disposal groups classified as 160 236 Total current liabilities 10,875 10,457 13,009 held for sale Total current assets 9,518 9,498 12,527 Non-current liabilities Debentures 24,488 25,686 28,982 Non-current assets Liabilities to banks 5,155 3,101 3,604 Inventory - fuel Liabilities with respect to other benefits after 1,624 1,618 1,546 6,874 6,759 5,449 employment termination Long-term receivables 2,294 2,463 2,208 Deferred taxes, net 7,198 7,265 8,390 Investment in associates 4 4 15 Liability to the State of Israel 1,793 1,787 1,859 Assets with respect to benefits after 8,280 8,842 10,672 Lease liabilities 542 570 451 employment termination Fixed assets, net 59,123 58,546 59,339 Other liabilities 592 577 519 Intangible assets, net 1,188 1,207 1,163 Total non current liabilities 46,642 45,745 49,254 Total non-current assets 72,513 72,680 74,943 Equity 28,825 29,145 32,623 Debit balance of regulatory deferral accounts 8,581 7,869 11,159 Credit balances of regulatory deferral accounts and deferred taxes with respect to regulatory deferral accounts 4,270 4,700 3,743 Total assets and debit balance of regulatory deferral accounts 90,612 90,047 98,629 Total liabilities, equity and credit balance of regulatory deferral accounts 90,612 90,047 98,629 Source: IEC's Financial Statements for 9M.2022 Investor Relations 39
View entire presentation